Evidence map›Paper›PMID 34540309›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Influenza epidemiology and burden of disease in Mongolia, 2013-2014 to 2017-2018.

Oyungerel Darmaa, Alexanderyn Burmaa, Baataryn Gantsooj, Badarchiin Darmaa, Pagbajabyn Nymadawa, Sheena G Sullivan, James E Fielding

Open access · diamondAbstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Oyungerel DarmaaNational Influenza Centre, National Centre of Communicable Diseases, Ulaanbaatar, Mongolia.
Alexanderyn BurmaaNational Influenza Centre, National Centre of Communicable Diseases, Ulaanbaatar, Mongolia.
Baataryn GantsoojNational Influenza Centre, National Centre of Communicable Diseases, Ulaanbaatar, Mongolia.
Badarchiin DarmaaNational Influenza Centre, National Centre of Communicable Diseases, Ulaanbaatar, Mongolia.
Pagbajabyn NymadawaNational Influenza Centre, National Centre of Communicable Diseases, Ulaanbaatar, Mongolia.
Sheena G SullivanWorld Health Organization Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
James E FieldingMelbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
National Influenza Center · MNMongolian Academy of Sciences · MNPeter Doherty Institute · AUThe Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMongolia is a vast, sparsely populated country in central Asia. Its harsh climate and nomadic lifestyle make the population vulnerable to acute respiratory infections, particularly influenza. Evidence on the morbidity, mortality and socioeconomic impact of influenza in Mongolia is scarce; however, routine surveillance for influenza-like illness (ILI), severe acute respiratory infection (SARI) and laboratory-detected influenza is conducted. This paper describes the epidemiology of influenza and the estimated burden of influenza-associated illness in Mongolia in the five influenza seasons between 2013-2014 and 2017-2018.

methodsDemographic and laboratory data from 152 sentinel surveillance sites on all patients who met the case definitions of ILI and SARI between October 2013 and May 2018 were extracted and analysed as described in

resultsThe estimated annual influenza-associated ILI and SARI rates, presented as ranges, were 1279-2798 and 81-666 cases per 100 000 population, respectively. Children aged < 5 years accounted for 67% of all ILI cases and 79% of all SARI cases. The annual specimen positivity for influenza was highest (11-30% for ILI and 8-31% for SARI) for children aged 5- < 15 years and children < 2 years old, respectively. The annual mortality rate due to pneumonia and SARI was highest among children aged < 2 years (15.8-54.0 per 100 000 population). Although the incidence of influenza-associated ILI and SARI was lowest for people aged

conclusionThe estimated influenza-associated ILI and SARI incidence rates are high in Mongolia, and children, especially those aged < 5 years, have the highest influenza-associated burden in Mongolia. These findings provide evidence for decision-makers in Mongolia to consider targeted influenza vaccination, particularly for children.

Indexed as

Cost of IllnessInfluenza, HumanChildChild, PreschoolHumansInfantMongoliaSeasonsSentinel Surveillance

Identifiers

PMID34540309
PMCPMC8421741
OpenAlexW3199813749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.